Publikation

Management of acute atrial fibrillation in the intensive care unit: An international survey

Wissenschaftlicher Artikel/Review - 06.12.2021

PubMed
DOI

Zitation
Wetterslev M, Lindqvist E, Myatra S, Kalvit K, Arabi Y, Szczeklik W, Sigurdsson M, Balik M, Keus F, Perner A, Cronhjort M, Siegemund M, Møller M, Granholm A, Hassager C, Haase N, Aslam T, Shen J, Young P, Åneman A, Hästbacka J, AFIB-ICU collaborators. Management of acute atrial fibrillation in the intensive care unit: An international survey. Acta Anaesthesiol Scand 2021
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Acta Anaesthesiol Scand 2021
Veröffentlichungsdatum
06.12.2021
eISSN (Online)
1399-6576
Kurzbeschreibung/Zielsetzung

BACKGROUND
Atrial fibrillation (AF) is common in intensive care unit (ICU) patients and is associated with poor outcomes. Different management strategies exist, but the evidence is limited and derived from non-ICU patients. This international survey of ICU doctors evaluated the preferred management of acute AF in ICU patients.

METHOD
We conducted an international online survey of ICU doctors with 27 questions about the preferred management of acute AF in the ICU, including antiarrhythmic therapy in hemodynamically stable and unstable patients and use of anticoagulant therapy.

RESULTS
A total of 910 respondents from 70 ICUs in 14 countries participated in the survey with 24%-100% of doctors from sites responding. Most ICUs (80%) did not have a local guideline for the management of acute AF. The preferred first-line strategy for the management of hemodynamically stable patients with acute AF was observation (95% of respondents), rhythm control (3%), or rate control (2%). For hemodynamically unstable patients, the preferred strategy was observation (48%), rhythm control (48%), or rate control (4%). Overall, preferred antiarrhythmic interventions included amiodarone, direct current cardioversion, beta-blockers other than sotalol, and magnesium in that order. A total of 67% preferred using anticoagulant therapy in ICU patients with AF, among whom 61% preferred therapeutic dose anticoagulants and 39% prophylactic dose anticoagulants.

CONCLUSION
This international survey indicated considerable practice variation among ICU doctors in the clinical management of acute AF, including the overall management strategies and the use of antiarrhythmic interventions and anticoagulants.